# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-033944
Filing Date
2024-11-07
Accepted
2024-11-07 16:29:45
Documents
75
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | sava20240930_10q.htm iXBRL | 10-Q | 1108066
2 | EXHIBIT 31.1 | ex_717369.htm | EX-31.1 | 13769
3 | EXHIBIT 31.2 | ex_717370.htm | EX-31.2 | 13872
4 | EXHIBIT 32.1 | ex_717371.htm | EX-32.1 | 7619
10 |  | a03.jpg | GRAPHIC | 49207
11 |  | cab1ac4300e0img001.jpg | GRAPHIC | 28347
12 |  | chart_2.jpg | GRAPHIC | 71417
13 |  | fig5.jpg | GRAPHIC | 41195
14 |  | figure01.jpg | GRAPHIC | 19318
15 |  | figure03.jpg | GRAPHIC | 20580
16 |  | figure04.jpg | GRAPHIC | 12107
17 |  | figure4b02.jpg | GRAPHIC | 22157
18 |  | figure5b02.jpg | GRAPHIC | 26019
19 |  | slide05.jpg | GRAPHIC | 45320
| Complete submission text file | 0001437749-24-033944.txt |  | 6217566

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | sava-20240930.xsd | EX-101.SCH | 51013
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | sava-20240930_cal.xml | EX-101.CAL | 35238
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | sava-20240930_def.xml | EX-101.DEF | 320522
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | sava-20240930_lab.xml | EX-101.LAB | 287428
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | sava-20240930_pre.xml | EX-101.PRE | 348623
78 | EXTRACTED XBRL INSTANCE DOCUMENT | sava20240930_10q_htm.xml | XML | 800430

Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41905 | Film No.: 241436315
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)